Opportunity Information: Apply for RFA DA 25 020

The Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional) funding opportunity (RFA-DA-25-020) is a discretionary NIH grant aimed at supporting early-stage, practice-focused research to test improved care models that bring HIV services, addiction treatment, and primary care into a more seamless, coordinated system. The central idea is to move beyond fragmented, referral-heavy approaches and instead evaluate enhanced, integrated service designs that can better reach people affected by HIV and substance use, improve engagement and retention in care, and strengthen overall health outcomes through coordinated primary care. Because this is an R34 mechanism and clinical trials are optional, the opportunity is geared toward pilot or developmental testing that can demonstrate feasibility, acceptability, and early signals of impact, often as a precursor to larger-scale effectiveness or implementation studies.

The opportunity is administered by the National Institutes of Health and falls under the Education and Health activity category, with CFDA number 93.279. The funding instrument is a grant, with an award ceiling listed at $450,000. The original application closing date is March 19, 2025. While the listing does not specify the exact number of expected awards, applicants should treat the ceiling and the R34 scope as a strong cue to propose a focused project with clear milestones, realistic recruitment or implementation targets (if applicable), and well-defined evaluation methods that match a developmental research stage rather than a full-scale multi-site trial.

Projects supported under this FOA are expected to test "enhanced models of care" that "optimally integrate" HIV, addiction, and primary care services. In practical terms, this can include models that co-locate services in one setting, tightly coordinate across partnering organizations, or redesign workflows so that patients can receive HIV prevention or treatment, evidence-based substance use services, and routine medical care in a coordinated way. Integrated models may involve shared care plans, interdisciplinary teams, harmonized screening and referral pathways, and approaches that reduce barriers such as transportation challenges, stigma, fragmented records, or inconsistent follow-up. Because the FOA emphasizes testing models, proposals typically need to spell out the intervention or model components, how integration will occur (clinically and operationally), the setting and target population, and how outcomes will be measured to show whether the model is workable and promising.

Eligibility is broad and includes many types of domestic organizations and government entities: state, county, and city/township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with or without 501(c)(3) status (excluding higher education institutions where noted); for-profit organizations other than small businesses; small businesses; and other applicant types. The FOA also explicitly highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations). This emphasis signals an interest in diverse institutional partners and community-rooted organizations that are well positioned to design and test integrated care approaches in real-world settings, including in underserved communities and jurisdictions disproportionately affected by HIV and substance use.

Overall, this FOA is best viewed as support for rigorous, developmental testing of integrated HIV, addiction, and primary care service models that can inform future scale-up. Competitive applications will typically present a clear integrated-care concept, demonstrate strong partnerships with clinical and community stakeholders, and include an evaluation plan that can credibly assess feasibility and early outcomes within the budget and timeline expected for an R34 project, with the option (but not requirement) to include a clinical trial component if it is appropriate for the model being tested.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2023-07-19.
  • Applicants must submit their applications by 2025-03-19. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $450,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DA 25 020

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for HIV and AIDS support

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Continuation of the Childhood Liver Disease Research Network (ChiLDReN) Clinical Centers (U01 Clinical Trial Required)

Previous opportunity: Youth Violence Prevention Interventions (R01 - Clinical Trial Required)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 25 020

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 25 020) also looked into and applied for these:

Funding Opportunity
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required) Apply for RFA DA 25 019

Funding Number: RFA DA 25 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required) Apply for RFA DA 25 002

Funding Number: RFA DA 25 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $225,000
Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional) Apply for RFA DA 25 001

Funding Number: RFA DA 25 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Apply for PAR 23 254

Funding Number: PAR 23 254
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Apply for PAR 23 255

Funding Number: PAR 23 255
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) Apply for PAR 23 245

Funding Number: PAR 23 245
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) Apply for PAR 23 259

Funding Number: PAR 23 259
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 23 243

Funding Number: PAR 23 243
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 23 242

Funding Number: PAR 23 242
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) Apply for PAR 23 264

Funding Number: PAR 23 264
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) Apply for PAR 23 273

Funding Number: PAR 23 273
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) Apply for PAR 23 244

Funding Number: PAR 23 244
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) Apply for PAR 23 270

Funding Number: PAR 23 270
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional) Apply for PAR 23 253

Funding Number: PAR 23 253
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) Apply for PAR 23 281

Funding Number: PAR 23 281
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) Apply for RFA CA 23 042

Funding Number: RFA CA 23 042
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional) Apply for RFA DA 25 018

Funding Number: RFA DA 25 018
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) Apply for PAR 23 279

Funding Number: PAR 23 279
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) Apply for PAR 23 280

Funding Number: PAR 23 280
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) Apply for PAR 24 027

Funding Number: PAR 24 027
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 25 020", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: